1. Home
  2. AMBQ vs RZLT Comparison

AMBQ vs RZLT Comparison

Compare AMBQ & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBQ
  • RZLT
  • Stock Information
  • Founded
  • AMBQ 2010
  • RZLT 2010
  • Country
  • AMBQ United States
  • RZLT United States
  • Employees
  • AMBQ N/A
  • RZLT N/A
  • Industry
  • AMBQ Semiconductors
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBQ Technology
  • RZLT Health Care
  • Exchange
  • AMBQ Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • AMBQ 673.1M
  • RZLT 626.4M
  • IPO Year
  • AMBQ 2025
  • RZLT N/A
  • Fundamental
  • Price
  • AMBQ $39.58
  • RZLT $7.12
  • Analyst Decision
  • AMBQ Buy
  • RZLT Strong Buy
  • Analyst Count
  • AMBQ 4
  • RZLT 5
  • Target Price
  • AMBQ $43.75
  • RZLT $12.50
  • AVG Volume (30 Days)
  • AMBQ 278.0K
  • RZLT 716.3K
  • Earning Date
  • AMBQ 09-04-2025
  • RZLT 09-18-2025
  • Dividend Yield
  • AMBQ N/A
  • RZLT N/A
  • EPS Growth
  • AMBQ N/A
  • RZLT N/A
  • EPS
  • AMBQ N/A
  • RZLT N/A
  • Revenue
  • AMBQ $76,589,000.00
  • RZLT N/A
  • Revenue This Year
  • AMBQ N/A
  • RZLT N/A
  • Revenue Next Year
  • AMBQ N/A
  • RZLT N/A
  • P/E Ratio
  • AMBQ N/A
  • RZLT N/A
  • Revenue Growth
  • AMBQ 50.25
  • RZLT N/A
  • 52 Week Low
  • AMBQ $32.89
  • RZLT $2.22
  • 52 Week High
  • AMBQ $51.76
  • RZLT $7.46
  • Technical
  • Relative Strength Index (RSI)
  • AMBQ N/A
  • RZLT 74.14
  • Support Level
  • AMBQ N/A
  • RZLT $6.23
  • Resistance Level
  • AMBQ N/A
  • RZLT $7.46
  • Average True Range (ATR)
  • AMBQ 0.00
  • RZLT 0.32
  • MACD
  • AMBQ 0.00
  • RZLT 0.03
  • Stochastic Oscillator
  • AMBQ 0.00
  • RZLT 77.59

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: